VanEck Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,754
Closed -$526K 1399
2024
Q4
$526K Sell
1,754
-80
-4% -$28K ﹤0.01% 1128
2024
Q3
$752K Buy
+1,834
New +$671K ﹤0.01% 1035
2024
Q1
Sell
-2,585
Closed -$700K 1389
2023
Q4
$700K Sell
2,585
-438
-14% -$108K ﹤0.01% 1005
2023
Q3
$744K Buy
+3,023
New +$827K ﹤0.01% 970
2021
Q3
Sell
-3,563
Closed -$737K 1306
2021
Q2
$737K Buy
3,563
+141
+4% +$28.7K ﹤0.01% 853
2021
Q1
$644K Buy
+3,422
New +$603K ﹤0.01% 814

Other funds holding HCA

VanEck Associates's HCA Position: Q1 2025 in Review

VanEck Associates sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 1,754 shares — an estimated $526K sold.

VanEck Associates first reported a position in HCA in Q1 2021 and held it in 6 quarters. The position peaked at $752K in Q3 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • VanEck Associates reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • VanEck Associates sold 1,754 HCA Healthcare shares in Q1 2025, an estimated $526K.
  • VanEck Associates first reported a position in HCA Healthcare in Q1 2021 and held it in 6 quarters.
  • VanEck Associates's HCA Healthcare position peaked at $752K in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on VanEck Associates's 13F filing for Q1 2025, filed 15 May 2025.